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rESUMO
introdução: A embolia pulmonar  é uma importante causa de mortalidade materna no mundo desenvolvido. A cintigrafia de ventilação-
perfusão e a tomografia computorizada causam exposição à radiação ionizante. A ressonância magnética com contraste-gadolínio 
endovenoso não é geralmente indicada em doentes grávidas. A RM utilizando técnicas resistentes aos artefactos de movimento, que 
não usam contraste endovenoso, como a balanced steady-state free precession (SSFP) poderá ser uma abordagem preferível em 
doentes grávidas.
Objectivo: Descrever os achados preliminares do uso de SSFP na avaliação de doentes grávidas com suspeita de EP, comparando 
com uma população de jovens mulheres avaliadas com RM 3D-gradiente eco após contraste-gadolínio pela mesma suspeita clínica.
Materiais e Métodos: O arquivo radiológico foi retrospectivamente analisado para dois grupos de doentes submetidos a RM do tórax 
em 1.5T por suspeita de EP, entre Janeiro de 2007 e Junho de 2010: grávidas com RM incluindo SSFP (grupo A) e mulheres com 
idade inferior a 45 anos com RM incluindo sequência ponderada em T1, 3D-GRE, após contraste-gadolínio (grupo B). A população 
final incluiu 21 doentes. As imagens de RM foram avaliadas com leitura independente e cega, para qualidade de imagem do sistema 
arterial pulmonar, EP e outros achados torácicos. Os dados foram submetidos a análise estatística.
resultados: A qualidade de imagem foi considerada boa em todas as artérias centrais e lobares de ambos os grupos e em pelo me-
nos 90% (grupo A) e 83,3% (grupo B) das artérias segmentares. Não ocorreram diferenças significativas na qualidade de imagem das 
artérias pulmonares centrais e lobares entre os grupos A e B (p > 0,05).
Conclusão: A RM com SSFP pode visualizar as artérias pulmonares centrais, lobares e segmentares em doentes grávidas, com 
qualidade de imagem adequada e comparável a 3D-GRE.
AbStrACt
introduction: Pulmonary embolism  is a leading cause of maternal mortality in the developed world. Ventilation-perfusion scintigraphy 
and Computer tomography cause ionizing radiation exposure. Gadolinium-enhanced magnetic resonance imaging is generally not 
indicated in pregnant patients. MRI using motion resistant techniques that do not use intravenous contrast material, such as balanced 
steady-state free precession may be a better approach in pregnant patients.
Purpose: To describe the preliminary findings of the use of SSFP for the evaluation of pregnant patients with suspected PE, and to 
compare with a young women population evaluated with postgadolinium 3D-gradient echo sequences for the same intention.
Materials and Methods: Radiology database was searched for two groups of subjects who underwent chest MRI at 1.5T for suspected 
PE, between January, 2007 and June, 2010: pregnant patients with MRI including balanced SSFP (group A) and females younger than 
45 years old including a T1-weighted postgadolinium 3D-GRE (group B) sequence. The final study population consisted of 21 subjects. 
Blind and independent evaluation of MR images was performed for image quality of the pulmonary arterial system, PE and other chest 
findings. Data was subject to statistical analysis.
results: Good image quality was observed in all central and lobar arteries on both groups and in 90% (group A) and at least 83.3% 
(group B) of the segmental arteries. There was no significant difference between groups A and B for image quality of central and lobar 
pulmonary arteries (p > 0.05).
Conclusion: SSFP can visualize central, lobar and segmental pulmonary arteries with sufficient image quality in pregnant patients, 
comparable to 3D-GRE.
iNtrODUCtiON
 Pulmonary embolism (PE) is a leading cause of ma-
ternal mortality in the developed world.1-4 The incidence of 
pulmonary embolism during pregnancy is five times greater 
than that for non-pregnant women of the same age.3 The 
ability to accurately diagnose PE is essential in order to 
treat this life-threatening condition or to prevent unneces-
sary treatment, as the treatment is associated with side ef-
fects for both mother and fetus.2-4 Clinical manifestation of 
PE is often nonspecific and variable, and the assignment 
of a clinical pretest probability for PE has not been proven 
effective in pregnancy leading to under- or misdiagnosis.1,5-7 
Because of this, imaging has assumed a central role in the 
diagnosis of PE.1
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nary angiography (CTPA) have been used as the first line 
imaging tests for the diagnosis of pulmonary embolism in 
pregnant patients, when compression US of the lower ex-
tremities does not result in a positive finding for deep vein 
thrombosis.1-6,8,9 Although with comparable results,10 the use 
of CTPA and/or V/Q scintigraphy have not been universally 
accepted as justifiable imaging strategies for the diagnosis 
of PE in pregnant patients because both modalities result 
in maternal and fetal radiation exposure.2-6,8,9 It has been 
reported that any amount of radiation exposure from these 
diagnostic examinations during pregnancy increases the 
lifetime risk of developing malignancy in the fetus and prolif-
erating breast tissue of the mother.2-4,8,11,12 Also, in the case 
of V/Q scans, up to 21% of pregnant women may have non-
diagnostic tests,13 and additional imaging might be needed, 
potentially exposing them to further radiation.1 In general, 
ionizing radiation techniques have been increasingly used 
during pregnancy for several conditions, with CT use in-
creasing by 25% per year.14 This concern with the potential 
deleterious effects associated with CT and iodinated con-
trast agents, and the fact that similar information may be 
obtained without the use of ionizing radiation or iodinated 
contrast media suggest the need to consider the benefits of 
the use of magnetic resonance imaging (MRI) for suspected 
PE in pregnant patients.15,16
 Gadolinium-enhanced MR angiography (MRA) has 
been shown to have high accuracy for the diagnosis of 
pulmonary embolism in the general population, its major 
potential limitation associated with image degradation due 
to motion artifacts.7,17-20 Other techniques, such as three di-
mensional gradient echo (3D-GRE) /volumetric interpolated 
breathhold examination (VIBE; Siemens, Erlangen, Ger-
many) sequences, which are able to evaluate the pulmo-
nary vasculature as well as other structures and organs in 
the chest, may be used in patients suspected to have PE. 
18,21-25 Recently, complementary benefits to combining dif-
ferent contrast enhanced and non contrast enhanced MRI 
approaches for evaluation of PE has been shown.26 How-
ever, gadolinium-enhanced MRI is generally not indicated 
in pregnant patients, because of safety concerns for the fe-
tus.9,14 In the absence of gadolinium, pregnant patients can 
undergo MRI, without reported cases of deleterious effect of 
MRI on the developing fetus.27 MRI protocols using motion 
resistant bright blood techniques that do not use intrave-
nous contrast material, such as balanced steady-state free 
precession techniques (SSFP) may be a better approach in 
this specific category of patients.18,22 Also, the difficulties of 
having pregnant patients in the magnet bore can be over-
come, given that these sequences have already shown suc-
cess in studying fetus’ cardiac anatomy without sedation.28
 Thus, the purpose of our study is to describe the pre-
liminary findings of the use of MRI including SSFP for the 
evaluation of pregnant patients with suspected pulmonary 
embolism, and to compare with a non-pregnant young 
women population evaluated with postgadolinium 3D-GRE 
sequences for the same intention.
MAtEriALS AND MEtHODS
Patient Selection
 Institutional review board approval with waiver of in-
formed consent was obtained for our HIPAA compliant ret-
rospective study. The Radiology Department database was 
searched for consecutive subjects who were pregnant and 
underwent chest MRI at 1.5 T including a balanced SSFP 
sequence (group A) and for female subjects younger than 
45 years old who underwent chest MRI at 1.5 T including a 
T1-weighted postgadolinium 3D-GRE sequence (group B), 
both for suspected pulmonary embolism, between January, 
2007 and June, 2010. The final study population consisted 
of 21 subjects. Group A included 6 subjects (mean age ± 
standard deviation, 26 ± 7.1) who were pregnant (mean 
gestational age ± standard deviation, 17 ± 2.5 weeks). 
None of the patients of group A had previous history of PE 
and/or deep vein thrombosis. Group B included 15 subjects 
(mean age ± standard deviation, 27 ± 6.8). Of these 15, 
three were pregnant, one did not have an appropriate in-
travenous access for computed tomography pulmonary 
angiogram (CTPA) and one could not tolerate ventilation/
perfusion (V/Q) scintigraphy. Additionally; 3 subjects had a 
past history of PE and/or deep vein thrombosis (DVT), 2 
subjects had factor V Leiden deficiency and 2 had sickle 
cell disease. The pregnancies were in the second trimes-
ter in all three subjects. All subjects from both groups were 
referred from the Emergency Department and had chief 
complaints including chest pain, dyspnea, syncope and ex-
tremity swelling, and underwent chest MRI for the evalua-
tion of suspected PE. MRI examinations were performed 
for suspected pulmonary embolism at admission. The de-
cisions to examine the subjects with MRI for suspected 
pulmonary embolism, including gadolinium administration, 
were made purely for clinical reasons and following discus-
sion of its risks and benefits with the referring physicians 
and subjects. Written informed consents about the risks and 
benefits of MRI examinations and gadolinium administra-
tion to the health of fetus and mother were obtained from 
all pregnant subjects. Pregnant subjects that underwent an 
MRI protocol with gadolinium administration did so in 2007, 
when our institution’s protocol included this approach in se-
lected cases.18,29,30
Mri technique
 MR imaging of the chest was performed on 1.5-T MR 
system (Avanto MRI System, Siemens Medical Systems, 
Malvern, PA) using a phased-array torso coil, according to 
our institution’s Chest MRI protocol for suspected pulmo-
nary embolism, which included a T1-weighted fat saturated 
pre and postgadolinium 3D-GRE (VIBE) sequence, as was 
the case of subjects included in group B. If contrast admin-
istration has deemed contraindicated, a balanced SSFP se-
quence, multi-slice 2D true fast imaging with steady-state 
precession (TrueFISP), was performed instead of the 3D-
GRE sequence, as was the case with subjects included in 
group A. All sequences were acquired in both coronal and 
axial planes. Intravenous gadobenate dimeglumine (Multi-
Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                361
Hance, Bracco Diagnostics, Princeton, NJ, USA) was ad-
ministered as a power-injected (Medrad, Pittsburgh, PA, 
USA) bolus of 0.1 mmol/kg at 2 ml/second in all subjects 
that underwent 3D-GRE. Postgadolinium 3D-GRE se-
quences were acquired at 5 seconds after the administra-
tion of gadolinium. Details of MRI protocol and sequences 
used for subjects with suspected pulmonary embolism are 
displayed in Table 1.
 TrueFISP, or true fast imaging steady-state free pre-
cession, is a gradient-echo technique with fully refocused 
transverse magnetization, its signal intensity characterized 
by the square root of T2/T1. Thus, it provides intensive 
blood signal (long T1 and T2). With short TE and short TR 
approaches, all tissues with a reasonably long T2-relaxation 
time will demonstrate additional signal due to the various 
refocused echo paths. These characteristics allow inherent 
discrimination of embolic material and patent pulmonary 
vessels/blood. This bright blood technique is able to visu-
alize the pulmonary vasculature as well as the lungs and 
other structures of the chest and may also be acquired as 
a single-shot technique in subjects who are not able to hold 
their breath due to respiratory distress.18,22,26
Mri interpretation
 Chest MRI studies of all subjects were independently 
and retrospectively evaluated by 2 experienced body radi-
ologists separately (R1 and R2 with 6 years and 5 years of 
experience, respectively) who were blinded to the clinical 
information and diagnosis of the subjects but were aware 
that pulmonary embolism was suspected.
 Reviewers evaluated all images of the pulmonary arte-
rial system for diagnostic image quality and the findings of 
pulmonary embolism to the level of segmental branches 
on SSFP or postgadolinium 3D-GRE sequences in all sub-
jects, according to previously published methods.18,20,22 Ad-
ditionally, the reviewers examined for other findings in other 
structures of the chest including lung parenchyma, heart, 
mediastinum, chest wall and diaphragm on all sequences. 
Table 1 – Sequences and parameters of chest MRI protocol used for pregnant patients with suspected pulmonary embolism
Sequences    trueFiSP*                  3D-GrE†
Planes Coronal Axial Coronal Axial
TR (ms)‡ 2.91 2.97 4.3 4.3
TE (ms)§ 1.44 1.48 1.68 1.68
Flip Angle (°) 60 60 10 10
Matrix 256x256 256x192 320x320 320x224
FOV (mm)|| 380 300 400 400
Number of Sections 50 50 72 72
Slice Thickness (mm) 5 5 3 3
Fat Suppression No No Yes Yes
Parallel Imaging (GRAPPA)¶ 2 2 2 2
Respiratory Control Breath hold Breath hold Breath hold Breath hold
Acquisition Time (s)** 13 13 21 21
* True fast imaging with steady-state precession; † Three dimensional gradient echo; ‡ Repetition time (milliseconds); § Echo time (milliseconds); || Field of view (millimeters);  
¶ Generalized autocalibrating partially parallel acquisitions; ** seconds.
Table 2 – Definitions of scores for the evaluation of image quality of pulmonary arteries
image Quality Scores Definitions
1 Poor image quality and blurring of the arterial segment
2 Fair image quality but inadequate blood signal intensity/arterial enhancement for confident diagnosis
3 Good image quality and blood signal intensity/arterial enhancement, and adequate definition for confident diagnosis
4 Excellent image quality and blood signal intensity/arterial enhancement for highly confident diagnosis
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The reviewers employed both coronal and axial datasets for 
SSFP and postgadolinium 3D-GRE sequences to evaluate 
the pulmonary arterial system.
 The parts of the pulmonary arterial system which were 
evaluated by the reviewers were as follows: main, right and 
left pulmonary arteries (central pulmonary arteries), five lo-
bar arteries (right upper, right middle, right lower, left upper, 
left lower), and 20 segmental arteries for a total of 28 parts. 
For each patient, 28 vessel parts were separately assessed 
for diagnostic image quality with regard to how clearly the 
vessel was defined by using a four point scale (1 - 4): poor 
image quality and blurring of the arterial segment (rated 1); 
fair image quality but inadequate blood signal intensity/ar-
terial enhancement for confident diagnosis (rated 2); good 
image quality and blood signal intensity/arterial enhance-
ment with adequate definition for confident diagnosis (rated 
3); and excellent image quality and blood signal intensity/
arterial enhancement for highly confident diagnosis (rated 
4). Image quality of an arterial segment was rated to have 
probable sufficient diagnostic quality (score of ≥ 3) if the 
reviewers were confident that clinically relevant diagnostic 
information was visible with clear discrimination between 
the blood vessel and background tissue.20 Image quality 
was considered nondiagnostic (score of ≤ 2) if the vessel 
was blurred or there was inadequate vessel signal intensity/
enhancement.20 Artifacts rendering the arterial parts nondi-
agnostic were also determined by the reviewers indepen-
dently.
 MRI findings diagnostic of PE were defined as a low sig-
nal intensity filling defect in an arterial part (seen in multiple 
projections) or abrupt cutoff of the main or lobar pulmonary 
arteries.19
Clinical and imaging Follow-up
 Clinical and imaging follow-up data for all subjects were 
obtained from the clinical information system and radiology 
database. Clinical follow-up included comorbid conditions 
(e.g. malignant disease, pulmonary infection) diagnosed 
at patient admission or during the subsequent hospitaliza-
tion, clinical course during or following hospitalization, the 
administration of anticoagulant treatment, course of the 
pregnancies, incidence of new PE and/or mortality during 
follow-up. The results of additional imaging tests performed 
for suspected PE at admission and later during the follow-
up were also obtained. The findings of the reviewers were 
compared to each other and the consensus data was also 
compared to the original MRI interpretation.
Statistical Analyses
 The extent of agreement between the reviewers for the 
evaluation of diagnostic image quality of pulmonary arter-
ies was calculated with Kappa statistics. Kappa values less 
than 0 were considered to represent no agreement; those 
between 0 and 0.40, poor agreement; those between 0.41 
and 0.75, good agreement; and those between 0.76 and 
1.00, excellent agreement. Mann-Whitney U test was used 
to test the null hypothesis that SSFP and postgadolinium 
3D-GRE sequences were not different from each other for 
the demonstration of separate parts of the pulmonary arte-
rial system based on the diagnostic image quality data. The 
significance of difference of the frequencies of diagnostic 
and nondiagnostic arterial parts between the two groups 
was calculated with Chi-square test for the comparison 
between proportions. Kruskal Wallis with post-hoc multiple 
comparisons were used to test the null hypothesis that di-
agnostic image quality of separate parts of the pulmonary 
arterial system was not different from each other on SSFP 
and postgadolinium 3D-GRE sequences separately. Asso-
ciations were considered statistically significant if two-tailed 
p < 0.05. Analyses were performed by using MedCalc for 
Windows, version 11.3.0.0 (Medcalc Software, Mariakerke, 
Belgium).
rESULtS
Pulmonary Arterial System Findings
 The rate of agreement between the reviewers for the 
evaluation of image quality of pulmonary arteries ranged 
from 0.66 to 1.0. All central (18/18) and lobar (30 / 30) pul-
monary arteries (both reviewers), as well as 90.6% (110 
/ 120; reviewer 1) and 90.8% (109 / 120; reviewer 2) of 
the segmental arteries were visualized with sufficient im-
age quality (≥ 3) on group A (Table 3) (Fig. 1). All central 
 
Fig. 1 – True Fast Imaging Steady-state free precession (TrueFISP) images (a,b,c) in the axial plane of a 30 year/old pregnant woman 
with suspected pulmonary embolism, showing different pulmonary vessel parts. Notice the good image quality, signal intensity and defini-
tion allowing for confident diagnosis of the main left pulmonary artery (a), emergence of the right superior lobar artery (arrow, a), the main 
right pulmonary artery (b) and segmental vessel parts including middle lobe and left lower lobe (arrows, c) pulmonary arteries . Notice the 
emergence of the left lower lobe segmental branches (arrow, b). No pulmonary embolism was found at chest MRI or suspected at clinical 
follow-up.
a b c
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Table 3 – Distribution of number of arterial parts with diagnostic image quality at different levels on groups A and B
 reviewer 1 reviewer 2
Vessel Parts Group A* Group b† Group A Group b
Central‡ 18/18 (100%)§ 45/45 (100%) 18/18 (100%) 45/45 (100%)
Lobar 30/30 (100%) 75/75 (100%) 30/30 (100%) 75/75 (100%)
Segmental 110/120 (90.6%) 259/300 (83.3%) 109/120 (90.8%) 272/300 (90.7%)
* Group A includes patients who underwent chest MRI using TrueFISP (True fast imaging with steady-state precession) in coronal and axial planes; † Group B includes patients who 
underwent chest MRI using post gadolinium 3D-GRE (Three dimensional gradient echo) in coronal and axial planes; ‡ Main, right and left pulmonary arteries; § Number of arterial parts 
with diagnostic image quality/ total number of arterial parts (proportion of diagnostic arterial parts).
(45 / 45), lobar (75 / 75), and 83.3% (259 / 300; reviewer 1) 
and 90.7% (272 / 300; reviewer 2) of the segmental arter-
ies were visualized with sufficient image quality in group B 
(Table 3) (Fig. 2).
 Ratings of the reviewers for the image quality of ves-
sel parts of the pulmonary arterial system are displayed in 
Table 4. Image quality ratings of central pulmonary arter-
ies were not significantly different from the ratings of lobar 
arteries on the SSFP sequence for both reviewers and on 
postgadolinium 3D-GRE sequence for one reviewer. Image 
quality of segmental arteries was significantly lower com-
pared to the ratings of central and lobar arteries on SSFP 
and postgadolinium 3D-GRE sequences for both reviewers 
(p < 0.0001). There was no significant difference between 
SSFP and postgadolinium 3D-GRE sequences for image 
quality of central (p = 0.23 for both reviewers) and lobar (p 
= 0.06 for reviewer 1 and p = 0.1 for reviewer 2) pulmonary 
arteries. Only reviewer 2 (R2) found significant differences 
Fig. 2 – True Fast Imaging Steady-state free precession (TrueFISP) images in the coronal (a,b) and in the axial (c) planes of a 28 year/
old pregnant woman and T1-weighted post-gadolinium three dimensional gradient-eco (3D-GRE) image in the coronal plane (d) of a 32 
year/old woman that underwent MRI for suspected pulmonary embolism. Good image quality, signal intensity and definition for confident 



























Fig. 3 – True Fast Imaging Steady-state free precession (TrueFISP) images in the coronal (a,b) and axial planes (c) of a 35 year/old preg-
nant woman with suspected pulmonary embolism and a history of metastatic breast carcinoma. Pericardial effusion causing right heart 
compromise which revealed an increase in size of the hepatic veins and inferior vena cava, was identified together with bilateral pleural 
effusions, bilateral atelectasis involving posterior regions of both lungs and perihilar parenchymal radiation changes.
between the scores of segmental pulmonary arteries with 
3D-GRE and SSFP. R2 found slightly lower and nondiag-
nostic calculated mean for the SSFP sequence, but there 
was no statistical significance of the difference of the pro-
portions of nondiagnostic studies between groups A (8.3%) 
and B (13.7%) (p = 0.1). Respiratory motion artifacts were 
determined as the cause of nondiagnostic image quality in 
all subjects in group B, and both poor blood signal intensity 
and motion artifacts in segmental arteries were considered 
the cause for nondiagnostic pulmonary artery parts depic-
tion in group A, by both reviewers.
 No filling defect in central, lobar or segmental pulmonary 
arteries and/or no abrupt cutoff of central or lobar pulmo-
nary arteries were detected by both reviewers in all sub-
jects included in group A. In Group B, PE was identified in 
one subject and the reviewers identified the involved arte-
rial segments in complete agreement in that subject. In this 
subject who had inadequate access for CTPA and a history 
of sickle cell disease, the diagnosis of PE was confirmed 
with V/Q scintigraphy performed within 24 h of chest MRI, 
which demonstrated high probability for PE. The involved 
arteries identified on MRI were concordant with the perfu-
sion defects seen in the involved segments of the lungs on 
V/Q scintigraphy.
 Other findings were detected in 2 / 6 subjects in group 
A and 3 / 15 subjects included in group B by both review-
ers. There was no discordance between the reviewers for 
the detection of other findings. In group A, subsegmental 
atelectasis was detected in the right middle lobe in one pa-
tient. In another patient with a history of metastatic breast 
carcinoma, pericardial effusion causing right heart compro-
mise which revealed an increase in size of the hepatic veins 
and inferior vena cava, was identified together with bilateral 
pleural effusions, bilateral atelectasis involving posterior 
regions of both lungs and perihilar parencyhmal radiation 
changes were detected (Fig. 3). In this patient, all seg-
mental arteries were rated as nondiagnostic on SSFP se-
quences. In Group B, one patient was found to have three 
lung nodules ranging from 2 to 6 mm in size on a follow-up 
CT within 24h, but only the largest lesion was identified on 
MRI. This difference did not impact patient management. In 
another patient, multiple areas of consolidations involving 
different segments of both lungs were detected, which was 
confirmed with chest X-rays and diagnosed as pneumonia 
clinically. In another patient who had sickle cell disease, su-
perior vena cava stenosis was detected and this was con-
firmed with venography and treated with venoplasty.
Clinical and imaging Follow-Up
 All subjects were followed up clinically for 4.7 ± 2.2 
months (group A) and 6.6 ± 3 months (group B) after MRI 
examinations. No subjects had additional imaging tests for 
the diagnosis of PE at admission. No subjects had clini-
cally suspected PE during the follow-up period. The patient 
who had the history of metastatic breast cancer was fur-
ther hospitalized and treated for cardiac tamponade. Histo-
pathologic proof was obtained that the pericardial effusion 
was malignant and secondary to breast cancer. Therapeutic 
abortion was also performed in this patient.
Table 4 – Results of the pulmonary arterial vessel parts analysis for both reviewers
 reviewer 1 reviewer 2
Vessel Parts Group A* Group b† P‡ Group A Group b P
Central§ 3.9 ± 0.2|| 3.8 ± 0.4 0.23 3.9 ± 0.2 3.8 ± 0.4 0.23
Lobar 3.8 ± 0.4 3.6 ± 0.5 0.06 3.7 ± 0.4 3.6 ± 0.5 0.1
Segmental 2.9 ± 0.3 3.0 ± 0.6 0.09 2.9 ± 0.3 3.1 ± 0.5 0.02
* Group A includes patients who underwent chest MRI using TrueFISP (True fast imaging with steady-state precession) in coronal and axial planes; † Group B includes patients 
who underwent chest MRI using post gadolinium 3D-GRE (Three dimensional gradient echo) in coronal and axial planes; ‡ Results of the Mann-Whitney U test. Associations 
were considered statistically significant if two-tailed P < 0.05; § Main , right and left pulmonary arteries; || Results of the pulmonary arterial vessel parts analysis are expressed as 
average±standard deviation. Scores range from 1(poor) to 4 (excelent) image quality and blood signal intensity/arterial enhancement.
a b c
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DiSCUSSiON
 The results of our study have shown that all central and 
lobar arteries and 90% of segmental arteries were visual-
ized with good image quality on SSFP sequences (group A). 
The success rate of SSFP sequences for the demonstration 
of lobar arteries in our study concurs with the reported suc-
cess rate of SSFP for vessel demonstration, which has been 
described as 99% accurate in recent studies.18,22 However, 
the success rate of SSFP sequences for the demonstration 
of segmental arteries was lower in our study compared to 
previous studies, which has been reported to be 97%.18,22
 Our study has also shown that all central, lobar and at 
least 83% of the segmental pulmonary arteries were visual-
ized successfully with sufficient diagnostic quality on postg-
adolinium 3D-GRE sequences. In our small population, re-
sults were comparable between the two approaches (groups 
A and B). The success rates of postgadolinium 3D-GRE 
sequences for the demonstration of lobar and segmental 
arteries concur with the success rates of MRA, which have 
been reported to vary in the range of 76-98% and 70-93%; 
respectively, in recent studies, with better results in the ab-
sence of motion artifacts.7,18,19 The ability to evaluate other 
organs in the chest is a major advantage of gadolinium en-
hanced 3D-GRE compared to MRA, as shown in a prior 
study, at least 50% of young adult patients investigation for 
PE have some abnormal finding in the chest.21
 Image quality ratings of segmental arteries were signifi-
cantly lower than that of central and lobar arteries on SSFP 
and 3D-GRE sequences. This finding is in agreement with 
the results of other studies in the literature.17-20,25
 One reported advantage of CTPA over MRI is the higher 
spatial resolution of CT which theoretically should result in 
better definition of small vessel, subsegmental pulmonary 
arterial emboli.15 The severity of PE has been related with 
its location, with severity increasing with more proximal lo-
cations.31 It is at present investigation whether treatment of 
isolated distal subsegmental PEs with heparin may result 
in greater patient morbidity than benefit.32-36 Patients diag-
nosed with isolated subsegmental pulmonary emboli have 
favorable 3-month outcomes. Short-term prognosis for re-
current thromboembolism may be lower than the risk of ad-
verse events with anticoagulation in patients at high risk of 
hemorrhage.37
 Motion artifacts are the most important factor associated 
with potential degradation of image quality of T1-weighted 
contrast enhanced MRI for the evaluation of the pulmonary 
vessels,7 which concurs with our results, as 13.7% of the 
arterial vessel parts of group B had nondiagnostic quality 
due to motion.
 This study reflects our clinical experience with imag-
ing pregnant patients for pulmonary embolism. No PE’s 
were detected in any of the arterial segments on MRI in 
any patient included in group A. No PE was observed in 
the pregnant patients in group B as well. Additional imag-
ing tests at admission and/or clinical and imaging follow-up 
confirmed this finding. This emphasizes that although the 
incidence of PE is higher in pregnancy than in other young 
patients, it is still a rare disease in this age group. The in-
cidence of venous thromboembolism in pregnant women 
has been estimated to be 5 – 12 events per 10,000 (0.05 
-0.12 %) pregnancies antenatally (from conception to de-
livery), pregnancy associated deep vein thrombosis (DVT) 
having an incidence about three times higher than that of 
pregnancy-associated PE.1-3 On the other hand, many dis-
ease processes in the chest and the physiologic changes 
of pregnancy may mimic the symptoms and signs of PE.1,3 
Additionally, pulmonary emboli in pregnant patients may be 
associated with related or unrelated findings that may affect 
therapeutic approaches.1,3 SSFP which is able to evaluate 
not only the pulmonary vasculature but also the lung paren-
chyma, heart, mediastinum, diaphragm and chest wall may 
render this method a useful technique for the examination 
of pregnant patients who have symptoms and signs sug-
gesting PE, but may in fact have other chest diseases. The 
detection of other findings in 2 / 6 (33%) of subjects in group 
A provides additional evidence of the value of a technique 
that evaluates the entire contents of the thorax.
 Postgadolinium 3D-GRE sequences have higher spatial 
and contrast resolution compared to the SSFP sequence; 
however, the latter has decided advantages, and should be 
preferred over postgadolinium 3D-GRE sequence in preg-
nant patients. SSFP does not require contrast administra-
tion, hence avoiding this risk, and can be acquired as a 
single shot technique in patients with respiratory distress, 
which renders it a motion resistant sequence.18,22 Current 
treatment options for PE depend on the prognostic stratifi-
cation of patients with PE. Mortality for PE is 2% in normo-
tensive patients without evidence of right ventricular dys-
function (RVD), but rises up to 30% in patients with shock 
and up to 65% in patients with cardiac arrest at presen-
tation.38 It has been reported that delay and misdiagnosis 
of pulmonary embolism is frequent, but much of this data 
comes from studies on the elderly.39 Imaging has been re-
ported to correlate well with prognostic stratification in some 
studies,40 but further validation is needed in larger popula-
tion studies and in pregnant patients6,40.
 Based on our findings, it may reasonable to consider us-
ing SSFP either as a first line modality, reserving postcon-
trast CT or V/Q for patients who have equivocal findings on 
SSFP, or to use SSFP as a short-term follow-up technique, 
after the diagnosis of PE has been established by CTPA or 
V/Q.41 Further validation of our findings is however needed 
before widespread implementation of our suggestion.
 Limitations of our study include the small sample size 
with its corresponding implications in statistical power, and 
the lack of detected PE in subjects evaluated with SSFP. 
It is conceivable that future studies may show significant 
differences that were not found in this study for the same 
tested parameters, although our rating results suggest that 
SSFP may potentially be used to evaluate pregnant patients 
with suspected PE. It is universally accepted that clear dem-
onstration of high signal in vessels is a definitive surrogate 
of the demonstration of patency of vessels and exclusion 
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flowing blood is high in signal intensity and clot is intermedi-
ate to low signal, hence we did not consider it a substantial 
set-back that no PE was present as we did not considered 
that SSFP required validation as an angiographic test.18,22 
The small population size may be also related with the ret-
rospective nature of our study and partly to the more limited 
access to MRI comparing to CTPA, as the MRI unit at our 
institution is not as close to the emergency department as 
the CT scanner. The choice of tests likely depends in part 
on physician practice styles and availability of tests. In fact, 
it has been reported that only 0.1% of the patients undergo 
MRI or MRA of the chest when PE is clinically suspected.42 
The recognized diagnostic value and at the same time easy 
access of CTPA often mitigates against the emergency de-
partment clinician requesting an MRI for the evaluation of 
PE.43 In a recent paper, 98% of emergency department phy-
sicians reported that CTPA was available at all hours and 
30% reported MRI either not available for PE diagnosis or 
not available at all hours.43 Another limitation is associated 
with the lack of a reference test in all subjects. The absence 
of a reference test in all subjects reflects the concern of 
radiation and contrast agents in pregnant patients at our 
institution. Notwithstanding its limitations, the study reflects 
our routine clinical practice and experience for pregnant pa-
tients with suspected PE.
CONCLUSiON
 Balanced SSFP imaging can visualize central, lobar and 
segmental arteries with sufficient image quality in pregnant 
patients, comparable to 3D-GRE, and thus may potentially 
be used to evaluate pregnant patients with suspected PE 
successfully. Further validation with prospective studies is 
necessary.
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